About Reactive Biosciences
Reactive Biosciences is a company based in Durham (United States) founded in 2021. Reactive Biosciences has raised $23.5 million across 2 funding rounds. Reactive Biosciences offers products and services including Reactor Platform. Reactive Biosciences operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and Enveda, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reactive Biosciences Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.5 M (USD)
in 2 rounds
-
Latest Funding Round
$4 M (USD), Debt – Conventional
Jun 28, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reactive Biosciences
Reactive Biosciences offers a comprehensive portfolio of products and services, including Reactor Platform.
Platform for developing boron-based medicines targeting undruggable diseases.
Funding Insights of Reactive Biosciences
Reactive Biosciences has successfully raised a total of $23.5M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Reactive Biosciences
Investment portfolio details for Reactive Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reactive Biosciences
Detailed financials for Reactive Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reactive Biosciences Comparisons
Peer comparison for Reactive Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reactive Biosciences
Reactive Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and Enveda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| Locked | Locked | Locked |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| Locked | Locked | Locked |
Provider of AI-based platform to decipher the chemistry of nature and develop new medicines
|
|
| Locked | Locked | Locked |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
Detailed competitors of Reactive Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reactive Biosciences
Complete news archive for Reactive Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reactive Biosciences
Reactive Biosciences was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Reactive Biosciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Julie Grant is the current CEO of Reactive Biosciences.
Reactive Biosciences is a funded company, having raised a total of $23.5M across 2 funding rounds to date.
Reactive Biosciences was founded in 2021 and is based in Durham, United States. Boron-based drug discovery platforms are utilized by the company to target undruggable diseases through computational approaches. Medicines for various conditions are developed, focusing on innovative therapeutic solutions in the biotechnology sector. Operations emphasize the advancement of novel treatments from discovery to potential clinical stages.
Reactive Biosciences offers Reactor Platform.